Literature DB >> 20040928

High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Nicholas T Vandehey1, Jeffrey M Moirano, Alexander K Converse, James E Holden, Jogesh Mukherjee, Dhanabalan Murali, R Jerry Nickles, Richard J Davidson, Mary L Schneider, Bradley T Christian.   

Abstract

(18)F-Fallypride and (11)C-FLB457 are commonly used PET radioligands for imaging extrastriatal dopamine D(2)/D(3) receptors, but differences in their in vivo kinetics may affect the sensitivity for measuring subtle changes in receptor binding. Focusing on regions of low binding, a direct comparison of the kinetics of (18)F-fallypride and (11)C-FLB457 was made using a MI protocol. Injection protocols were designed to estimate K(1), k(2), f(ND)k(on), B(max), and k(off) in the midbrain and cortical regions of the rhesus monkey. (11)C-FLB457 cleared from the arterial plasma faster and yielded a ND space distribution volume (K(1)/k(2)) that is three times higher than (18)F-fallypride, primarily due to a slower k(2) (FAL:FLB; k(2)=0.54 min(-1):0.18 min(-1)). The dissociation rate constant, k(off), was slower for (11)C-FLB457, resulting in a lower K(Dapp) than (18)F-fallypride (FAL:FLB; 0.39 nM:0.13 nM). Specific D(2)/D(3) binding could be detected in the cerebellum for (11)C-FLB457 but not (18)F-fallypride. Both radioligands can be used to image extrastriatal D(2)/D(3) receptors, with (11)C-FLB457 providing greater sensitivity to subtle changes in low-receptor-density cortical regions and (18)F-fallypride being more sensitive to endogenous dopamine displacement in medium-to-high-receptor-density regions. In the presence of specific D(2)/D(3) binding in the cerebellum, reference region analysis methods will give a greater bias in BP(ND) with (11)C-FLB457 than with (18)F-fallypride.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040928      PMCID: PMC2897717          DOI: 10.1038/jcbfm.2009.270

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  34 in total

1.  Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET.

Authors:  Tetsuya Suhara; Yasuhiko Sudo; Takashi Okauchi; Jun Maeda; Koichi Kawabe; Kazutoshi Suzuki; Yoshiro Okubo; Yoshifumi Nakashima; Hiroshi Ito; Shuji Tanada; Christer Halldin; Lars Farde
Journal:  Int J Neuropsychopharmacol       Date:  1999-06       Impact factor: 5.176

2.  Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.

Authors:  H Olsson; C Halldin; C G Swahn; L Farde
Journal:  J Cereb Blood Flow Metab       Date:  1999-10       Impact factor: 6.200

3.  Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach.

Authors:  J Delforge; M Bottlaender; C Loc'h; I Guenther; C Fuseau; B Bendriem; A Syrota; B Mazière
Journal:  J Cereb Blood Flow Metab       Date:  1999-05       Impact factor: 6.200

4.  Estimation of local receptor density, B'max, and other parameters via multiple-injection positron emission tomography experiments.

Authors:  Evan D Morris; Bradley T Christian; Karmen K Yoder; Raymond F Muzic
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

5.  Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol.

Authors:  Bradley T Christian; Tanjore Narayanan; Bing Shi; Evan D Morris; Joseph Mantil; Jogeshwar Mukherjee
Journal:  J Cereb Blood Flow Metab       Date:  2004-03       Impact factor: 6.200

Review 6.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

Review 7.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

8.  Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics.

Authors:  Evan D Morris; Karmen K Yoder
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-21       Impact factor: 6.200

9.  The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.

Authors:  Bradley T Christian; Nicholas T Vandehey; Andrew S Fox; Dhanabalan Murali; Terrence R Oakes; Alex K Converse; Robert J Nickles; Steve E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Neuroimage       Date:  2008-10-29       Impact factor: 6.556

10.  Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.

Authors:  Patrizia Riccardi; Ron Baldwin; Ronald Salomon; Sharlet Anderson; Mohammad S Ansari; Rui Li; Benoit Dawant; Amy Bauernfeind; Dennis Schmidt; Robert Kessler
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

View more
  31 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Elizabeth O Ahlers; Maxim Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-04       Impact factor: 6.200

3.  Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.

Authors:  Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

4.  Quantitative PET imaging of radioligands with slow kinetics in human brain.

Authors:  Sandra M Sanabria-Bohórquez; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-25       Impact factor: 9.236

5.  Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.

Authors:  Robert H Mach; Zhude Tu; Jinbin Xu; Shihong Li; Lynne A Jones; Michelle Taylor; Robert R Luedtke; Colin P Derdeyn; Joel S Perlmutter; Mark A Mintun
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

6.  Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.

Authors:  Christin Schifani; Sina Hafizi; Huai-Hsuan Tseng; Cory Gerritsen; Miran Kenk; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Romina Mizrahi
Journal:  Schizophr Res       Date:  2018-11-06       Impact factor: 4.939

7.  Cocaine cue-induced dopamine release in the human prefrontal cortex.

Authors:  Michele S Milella; Aryandokht Fotros; Paul Gravel; Kevin F Casey; Kevin Larcher; Jeroen A J Verhaeghe; Sylvia M L Cox; Andrew J Reader; Alain Dagher; Chawki Benkelfat; Marco Leyton
Journal:  J Psychiatry Neurosci       Date:  2016-08       Impact factor: 6.186

8.  The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations.

Authors:  Ingo Vernaleken; Lisa Peters; Mardjan Raptis; Robert Lin; Hans-Georg Buchholz; Yun Zhou; Oliver Winz; Frank Rösch; Peter Bartenstein; Dean F Wong; Wolfgang M Schäfer; Gerhard Gründer
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-18       Impact factor: 6.200

9.  Imaging the Biodistribution and Performance of Transplanted Stem Cells with PET.

Authors:  Christopher G England; Emily B Ehlerding; Weibo Cai
Journal:  J Nucl Med       Date:  2016-05-19       Impact factor: 10.057

10.  5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Dana L Tudorascu; Elizabeth O Ahlers; Maxim S Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  Neuroimage       Date:  2013-03-26       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.